CoChat

Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients

Open access
Phielix, Esther, Schrauwen-Hinderling, Vera B., Mensink, Marco, Lenaers, Ellen, Meex, Ruth, Hoeks, Joris, Kooi, Marianne Eline, Moonen-Kornips, Esther, Sels, Jean-Pierre, Hesselink, Matthijs K.C., Schrauwen, Patrick · 2008 · Diabetes

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index; 7 of the 22 sources its claims cite were checked for support.

Abstract

OBJECTIVE—A lower in vivo mitochondrial function has been reported in both type 2 diabetic patients and first-degree relatives of type 2 diabetic patients. The nature of this reduction is unknown. Here, we tested the hypothesis that a lower intrinsic mitochondrial respiratory capacity may underlie lower in vivo mitochondrial function observed in diabetic patients. RESEARCH DESIGN AND METHODS—Ten overweight diabetic patients, 12 first-degree relatives, and 16 control subjects, all men, matched for age and BMI, participated in this study. Insulin sensitivity was measured with a hyperinsulinemic-euglycemic clamp. Ex vivo intrinsic mitochondrial respiratory capacity was determined in permeabilized skinned muscle fibers using high-resolution respirometry and normalized for mitochondrial content. In vivo mitochondrial function was determined by measuring phosphocreatine recovery half-time after exercise using 31P-magnetic resonance spectroscopy. RESULTS—Insulin-stimulated glucose disposal was lower in diabetic patients compared with control subjects (11.2 ± 2.8 vs. 28.9 ± 3.7 μmol · kg−1 fat-free mass · min−1, respectively; P = 0.003), with intermediate values for first-degree relatives (22.1 ± 3.4 μmol · kg−1 fat-free mass · min−1). In vivo mitochondrial function was 25% lower in diabetic patients (P = 0.034) and 23% lower in first-degree relatives, but the latter did not reach statistical significance (P = 0.08). Interestingly, ADP-stimulated basal respiration was 35% lower in diabetic patients (P = 0.031), and fluoro-carbonyl cyanide phenylhydrazone–driven maximal mitochondrial respiratory capacity was 31% lower in diabetic patients (P = 0.05) compared with control subjects with intermediate values for first-degree relatives. CONCLUSIONS—A reduced basal ADP-stimulated and maximal mitochondrial respiratory capacity underlies the reduction in in vivo mitochondrial function, independent of mitochondrial content. A reduced capacity at both the level of the electron transport chain and phosphorylation system underlies this impaired mitochondrial capacity.

Overview

CoChat Summary

TL;DR

In male type 2 diabetic patients, in vivo mitochondrial function (phosphocreatine recovery half-time) was 25% lower than in age- and BMI-matched control subjects, and ex vivo ADP-stimulated state 3 respiration was 35% lower after normalization for mitochondrial content. These intrinsic defects involved both electron transport chain and phosphorylation system capacity, with intermediate or tendency values in first-degree relatives.

Key findings

  • Insulin-stimulated glucose disposal was lower in diabetic patients than control subjects (11.2 ± 2.8 vs. 28.9 ± 3.7 μmol · kg−1 fat-free mass · min−1, P = 0.003), with intermediate values in first-degree relatives (22.1 ± 3.4 μmol · kg−1 fat-free mass · min−1).
  • In vivo mitochondrial function was 25% lower in diabetic patients (PCr recovery half-time 23.8 ± 2.0 vs. 17.9 ± 1.2 s, P = 0.034); first-degree relatives had a 23% longer PCr-t1/2 (23.1 ± 2.0 s) but this did not reach significance (P = 0.08).
  • After normalization for mitochondrial content, ADP-stimulated state 3 respiration was 35% lower in diabetic patients (P = 0.031), and FCCP-driven maximal respiratory capacity was 31% lower (P = 0.05); state 4 respiration did not differ between groups.
  • Mitochondrial density (mtDNA copy number and citrate synthase activity) did not differ between groups, indicating that the lower respiration was intrinsic rather than due to reduced mitochondrial content.

Methods

  • Cross-sectional study of 10 male type 2 diabetic patients, 12 male first-degree relatives, and 16 male control subjects matched for age and BMI; insulin sensitivity was measured with a 3-h hyperinsulinemic-euglycemic clamp using [6,6-2H2]glucose.
  • In vivo mitochondrial function was determined by 31P-MRS as phosphocreatine recovery half-time after knee-extension exercise; ex vivo mitochondrial respiration was measured by high-resolution respirometry in permeabilized skinned muscle fibers, with normalization to mtDNA copy number or citrate synthase activity.
  • Group differences were analyzed by one-way ANOVA with Tukey’s post hoc correction; Spearman correlations were computed; significance was set at P < 0.05.

Limitations

  • Stated: physical activity was assessed by questionnaire and maximal aerobic capacity and was similar between groups, but the paper notes the reason for lower intrinsic mitochondrial capacity is unknown and may involve ultrastructural mitochondrial changes; whether mitochondrial size determines overall capacity needs further investigation.
  • Evident: all participants were men, group sizes were modest (10 diabetic patients, 12 first-degree relatives, 16 control subjects), and first-degree relative differences were not statistically significant (e.g., PCr-t1/2 P = 0.08), limiting power and generalizability.
  • Evident: the cross-sectional design cannot establish whether intrinsic mitochondrial defects precede or are a consequence of type 2 diabetes or insulin resistance.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.2337/db08-0391

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

FIG. 1. Metabolic flexibility, measured as the change in respiratory quotient from the fasted state to the insulin-stimulated condition, in control subjects, first-degree relatives, and diabetic patients. □, control;, FDR; ▪, type 2 diabetic patients. *P < 0.05 compared with diabetic patients.
FIG. 1. Metabolic flexibility, measured as the change in respiratory quotient from the fasted state to the insulin-stimulated condition, in control subjects, first-degree relatives, and diabetic patients. □, control;, FDR; ▪, type 2 diabetic patients. *P < 0.05 compared with diabetic patients.CC BY-NC-ND · PubMed Central
FIG. 2. In vivo mitochondrial function expressed as PCr half-time (s) in control subjects, first-degree relatives, and diabetic patients. □, control;, FDR; ▪, type 2 diabetic patients. *P < 0.05 compared with diabetic patients.
FIG. 2. In vivo mitochondrial function expressed as PCr half-time (s) in control subjects, first-degree relatives, and diabetic patients. □, control;, FDR; ▪, type 2 diabetic patients. *P < 0.05 compared with diabetic patients.CC BY-NC-ND · PubMed Central
FIG. 3. Ex vivo state 3 (A) and state u respiration (B) normalized for mitochondrial content expressed as pmol · (s · mg)−1 · mtDNA copy number−1 (×10.000) in control subjects, first-degree relatives, and diabetic patients. □, control;, FDR; ▪, type 2 diabetic patients. *P < 0.05 compared with diabetic patients.
FIG. 3. Ex vivo state 3 (A) and state u respiration (B) normalized for mitochondrial content expressed as pmol · (s · mg)−1 · mtDNA copy number−1 (×10.000) in control subjects, first-degree relatives, and diabetic patients. □, control;, FDR; ▪, type 2 diabetic patients. *P < 0.05 compared with diabetic patients.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

5 Valid · 0 Not valid · 10 Not checked · 62 Own results and interpretations

40 more claims

Create a free account to see all 77 claims and to verify the 15 references still open.

See all claims — free account
  • It may state two separate claims as one. 25
  • Probably not a substantial claim. 9

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

7 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Cited by

See all 359

Metadata

Authors
Phielix, E., Schrauwen-Hinderling, V. B., Mensink, M., Lenaers, E., Meex, R., Hoeks, J., Kooi, M. E., Moonen-Kornips, E., Sels, J.-P., Hesselink, M. K. C., & Schrauwen, P.
Affiliations
  • Department of Human Biology, Maastricht University, Maastricht, the Netherlands
  • Maastricht University (NL)
  • Maastricht University Medical Centre (NL)
Corresponding author
Schrauwen, Patrick
Venue
Diabetes
Published
2008-11-01
Volume
57
Issue
11
Pages
2943-2949
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2112906476
Cited by
359
References
31
Citations by year
2026: 5 · 2025: 14 · 2024: 13 · 2023: 26 · 2022: 28 · 2021: 26 · 2020: 20 · 2019: 17 · 2018: 14 · 2017: 12 · 2016: 28 · 2015: 13 · 2014: 17 · 2013: 25 · 2012: 29
FWCI
9.73
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, cc-by-nc-nd)
  • TU/e Research Portal (publishedVersion)
  • Socio-Environmental Systems Modeling (acceptedVersion)
  • TU/e Research Portal (submittedVersion)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Funders
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (016.066.359)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
type 2 diabetes, mitochondrial dysfunction, ADP-stimulated respiration, skeletal muscle, first-degree relatives, insulin sensitivity, insulin-stimulated glucose disposal, phosphocreatine recovery, electron transport chain, mitochondrial phosphorylation, F1-ATPase
MeSH terms
Adenosine Diphosphate, Diabetes Mellitus, Type 2, Glucose, Humans, Insulin, Male, Middle Aged, Mitochondria, Muscle, Cell Respiration, Carbohydrate Metabolism, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.